2005
DOI: 10.1016/j.accreview.2005.11.063
|View full text |Cite
|
Sign up to set email alerts
|

Reversal of Cardiomyopathy in Patients With Repetitive Monomorphic Ventricular Ectopy Originating From the Right Ventricular Outflow Tract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
84
0
2

Year Published

2007
2007
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(89 citation statements)
references
References 0 publications
3
84
0
2
Order By: Relevance
“…However, patients who satisfied the inclusion criteria in our study had been symptomatic for a long period and were not responsive to usual antiarrhythmic drugs. To date, the results of some successful clinical studies [12][13][14][15][16][17][18] have left several questions unanswered regarding radiofrequency catheter ablation of RVOT-PVC. Examples of these include the possibility of spontaneous remission of RVOT-PVC, RFA success predictor factors, the possibility of ablation by the epicardial route in failure cases, and the possibility of immediate relapses seen on the Holter test in the first 24 hours of the RFA.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, patients who satisfied the inclusion criteria in our study had been symptomatic for a long period and were not responsive to usual antiarrhythmic drugs. To date, the results of some successful clinical studies [12][13][14][15][16][17][18] have left several questions unanswered regarding radiofrequency catheter ablation of RVOT-PVC. Examples of these include the possibility of spontaneous remission of RVOT-PVC, RFA success predictor factors, the possibility of ablation by the epicardial route in failure cases, and the possibility of immediate relapses seen on the Holter test in the first 24 hours of the RFA.…”
Section: Discussionmentioning
confidence: 99%
“…Other symptoms were more diverse among the patients. Intriguing symptoms were dyspnea and fatigue experienced by 18 demonstrated cases of tachycardiomyopathy secondary to RVOT-PVC, justifying intervention with RFA. In our series, we did not observe this characteristic of RVOT-PVC, which we believe to be quite uncommon.…”
Section: Discussionmentioning
confidence: 99%
“…Other implicated arrhythmias are atrial fibrillation, atrial flutter, atrioventricular nodal reentrant tachycardia, ventricular tachycardia and frequent ventricular premature beats (16)(17)(18)(19).…”
Section: Discussionmentioning
confidence: 99%
“…It is considered to be a potentially reversible cause of heart failure. With appropriate heart rate and/or rhythm control, clinical, hemodynamic and structural parameters may normalize in as early as four weeks (160,(162)(163)(164)(165). Treatment of heart failure should follow the CCS heart failure guidelines (5), with additional emphasis on correcting and controlling the underlying causative rhythm.…”
Section: Consensus Conference Recommendations On Heart Failure 2008mentioning
confidence: 99%
“…In atrial fibrillation, rhythm control may require antiarrhythmic drugs or interventions, recognizing that these patients have not been studied extensively in clinical trials. Electrical control and/or electrophysiological ablation may be necessary for resistant tachyarrhythmias (163,164). Clinicians should be aware that future episodes of tachycardia may result in more rapid deterioration in systolic function and that, although infrequent, sudden cardiac death has been reported (165).…”
Section: Consensus Conference Recommendations On Heart Failure 2008mentioning
confidence: 99%